METHOD TO ASSESS POTENCY OF VIRAL VECTOR PARTICLES
Provided herein are cells, methods, kits and articles of manufacture, including those related to assessing the potency of viral vectors. The present disclosure relates to a method for screening for potency of a viral vector, including vectors which encode recombinant receptors that contain an extrac...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
07.02.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are cells, methods, kits and articles of manufacture, including those related to assessing the potency of viral vectors. The present disclosure relates to a method for screening for potency of a viral vector, including vectors which encode recombinant receptors that contain an extracellular antigen-binding domain and an intracellular signaling domain, such as a chimeric antigen receptor (CAR). The methods include assessing potency of a viral vector based on a detectable or measurable expression or activity of a reporter molecule(s) that are responsive to a signal through the intracellular signaling region of the T cell receptor e.g., recombinant receptor. |
---|---|
Bibliography: | Application Number: EP20220719658 |